Browsing by Author "Yue Wang"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Publication Metadata only Evaluation of rapid igg4 test for diagnosis of gnathostomiasis(2021-06-01) Yue Wang; An Ma; Xiao Long Liu; Praphathip Eamsobhana; Xiao Xian Gan; Siriraj Hospital; Hangzhou Medical College; Chinese Center for Disease Control and PreventionHuman gnathostomiasis is a parasitic disease caused by Gnathostoma nematode infection. A rapid, reliable, and practical immunoassay, named dot immuno-gold filtration assay (DIGFA), was developed to supporting clinical diagnosis of gnathostomiasis. The practical tool detected anti-Gnathostoma-specific IgG4 in human serum using crude ex-tract of third-stage larvae as antigen. The result of the test was shown by anti-human IgG4 monoclonal antibody conju-gated colloidal gold. The sensitivity and specificity of the test were both 100% for detection in human sera from patients with gnathostomiasis (13/13) and from healthy negative controls (50/50), respectively. Cross-reactivity with heterogonous serum samples from patients with other helminthiases ranged from 0 (trichinosis, paragonimiasis, clonorchiasis, schisto-somiasis, and cysticercosis) to 25.0% (sparganosis), with an average of 6.3% (7/112). Moreover, specific IgG4 antibodies diminished at 6 months after treatment. This study showed that DIGFA for the detection of specific IgG4 in human sera could be a promising tool for the diagnosis of gnathostomiasis and useful for evaluating therapeutic effects.Publication Metadata only The plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of p. vivax(2013-05-01) Yang Cheng; Yue Wang; Daisuke Ito; Deok Hoon Kong; Kwon Soo Ha; Jun Hu Chen; Feng Lu; Jian Li; Bo Wang; Eizo Takashim; Jetsumon Sattabongkot; Takafumi Tsuboi; Eun Taek Han; Kangwon National University; Ehime University; Mahidol University; Zhejiang Academy of Medical Sciences; Chinese Center for Disease Control and Prevention; Jiangsu Institute of Parasitic DiseasesMerozoite surface protein 1 of Plasmodium vivax (PvMSP1), a glycosylphosphatidylinositol-anchored protein (GPI-AP), is a malaria vaccine candidate for P. vivax. The paralog of PvMSP1, named P. vivax merozoite surface protein 1 paralog (PvMSP1P; PlasmoDB PVX_099975), was recently identified and predicted as a GPI-AP. The similarities in genetic structural characteristics between PvMSP1 and PvMSP1P (e.g., size of open reading frames, two epidermal growth factor-like domains, and GPI anchor motif in the C terminus) led us to study this protein. In the present study, different regions of the PvMSP1P protein, demarcated based on the processed forms of PvMSP1, were expressed successfully as recombinant proteins [i.e., 83 (A, B, and C), 30, 38, 42, 33, and 19 fragments]. We studied the naturally acquired immune response against each fragment of recombinant PvMSP1P and the potential ability of each fragment to bind erythrocytes. The N-terminal fragment (83A) and two C-terminal fragments (33 and 19) reacted strongly with sera from P. vivax-infected patients, with 50 to 68% sensitivity and 95 to 96% specificity, respectively. Due to colocalization of PvMSP1P with PvMSP1, we supposed that PvMSP1P plays a similar role as PvMSP1 during erythrocyte invasion. An in vitro cytoadherence assay showed that PvMSP1P, especially the 19-kDa C-terminal region, could bind to erythrocytes. We also found that human sera from populations naturally exposed to vivax malaria and antisera obtained by immunization using the recombinant molecule PvMSP1P-19 inhibited in vitro binding of human erythrocytes to PvMSP1P-19. These results provide further evidence that the PvMSP1P might be an essential parasite adhesion molecule in the P. vivax merozoite and is a potential vaccine candidate against P. vivax. © 2013, American Society for Microbiology.
